The Impact of Minimal Residual Disease (MRD) Testing on the Decision-Making Process in Non-Small-Cell Lung Cancer (NSCLC). - Gillis, Roni; Zahavi, Tamar; Peled, Nir; Yaacov, Adar; Afifi, Basel; Salim, Jaber; Basheer, Reham; Asna, Noam; Makori, Arnon; Peer, Michael; Gershman, Evgeni; Manaster, Yoav; et al. (Cancers, 2026)